Richmond's Phlow closes $36M Series B round

Richmond pharmaceutical company Phlow Corp. recently completed a $36 million Series B round that it will use to grow its commercial and manufacturing businesses. The company did not divulge the names of the participants in the round, but said it included new and existing investors. “The Series B raise is a great testament to the progress we have made,” Phlow President Dan Hackman said. “It allows us to make great progress in the coming years.” Phlow was founded in early 2020 by Eric Edwards…
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Source Type: news